News

Posted On: 01/02/2007

Chattem Acquires Five Consumer Brands from Johnson & Johnson

PharmaManufacturing.com

Chattem, Inc., a Chattanooga, Tenn.-based manufacturer of branded consumer drug products, has completed acquisition of the U.S. rights to five leading consumer and over-the-counter (OTC) brands from Johnson & Johnson for $410 million in cash.

Chattem's brand portfolio now includes Act, an anti-cavity mouthwash; Unisom, an OTC sleep aid; Cortizone, a hydrocortisone anti-itch product; Kaopectate, an anti-diarrhea product; and Balmex, a diaper rash product. The acquired brands were divested as a result of certain regulatory requirements connected with Johnson & Johnson's recent acquisition of Pfizer Inc.'s Consumer Healthcare business.